Clinical Trials
8 trialsNCT04396860 2026-04-22
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04474353 2025-12-26
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
Stanford University
Phase 1 Completed
NCT03801902 2025-09-23
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
National Cancer Institute (NCI)
Phase 1 Completed
NCT05510596 2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA Completed
NCT04722120 2022-02-14
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
Seoul National University Hospital
Phase NA Completed
NCT03176979 2021-11-18
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
University of Southern California
Phase NA Completed
NCT02117115 2015-06-11
GVHD
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT00242034 2008-09-03
Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques
University Health Network, Toronto
Phase NA Completed